Aethlon Medical Inc (NASDAQ:AEMD) on Focus After Report of Less Shorts

September 14, 2018 - By Margaret Downey

Aethlon Medical, Inc. (NASDAQ:AEMD) Logo

The stock of Aethlon Medical Inc (NASDAQ:AEMD) registered a decrease of 4.53% in short interest. AEMD’s total short interest was 1.34 million shares in September as published by FINRA. Its down 4.53% from 1.40M shares, reported previously. With 94,000 shares average volume, it will take short sellers 14 days to cover their AEMD’s short positions.

The stock increased 2.00% or $0.02 during the last trading session, reaching $1.02. About 8,318 shares traded. Aethlon Medical, Inc. (NASDAQ:AEMD) has declined 62.70% since September 14, 2017 and is downtrending. It has underperformed by 78.32% the S&P500.

Aethlon Medical, Inc., a medical device company, focuses on creating devices that address unmet medical needs in health and biodefense worldwide. The company has market cap of $18.15 million. The firm is developing Aethlon Hemopurifier, a clinical-stage therapeutic device for the single-use removal of life-threatening viruses from the circulatory system of infected individuals. It currently has negative earnings. It is also involved in the development of exosome products to diagnose and monitor neurological disorders and cancer; and a therapeutic device to reduce the incidence of sepsis, a fatal bloodstream infection.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: